Movement Alert|Salesforce.com Rises 12.84% in Pre-Market Trading, Q2 Earnings Massively Beat Expectations with Anthropic Partnership Accelerating AI Commercialization

Market Focus
Aug 27

On August 27, Salesforce.com rose 12.84% in pre-market trading, trading at $232.12/share, with turnover of $9.39 million.

On the news front, the company reported fiscal Q2 results after the prior session close that significantly exceeded market expectations. Adjusted EPS came in at $5.90, an 80.43% beat over the consensus estimate of $3.27 and a 102.75% increase year-over-year from $2.91. Revenue reached $11.345 billion versus the $11.320 billion estimate. The company raised full-year fiscal 2027 revenue guidance to $46.1 billion-$46.4 billion, compared to the FactSet consensus of $46.11 billion, while Q3 revenue guidance of $11.42 billion-$11.5 billion also came in slightly above expectations.

Additionally, Salesforce.com announced an expanded strategic partnership with Anthropic, launching a new product called Claudeforce. The Claude integration is now available to pilot customers, with a public beta expected in September, signaling accelerated AI commercialization. The company also noted its $25 billion accelerated share repurchase program is expected to complete final delivery by October. Prior to the report, software sector stocks had surged 24% over the preceding month, with all 13 software companies that had reported earnings beating estimates.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10